{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:54:26Z","timestamp":1778536466617,"version":"3.51.4"},"reference-count":55,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0188","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:19:26Z","timestamp":1525252766000},"source":"Crossref","is-referenced-by-count":17,"title":["Skin Changes Following Organ Transplantation"],"prefix":"10.3238","author":[{"given":"Claas","family":"Ulrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Frei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Hetzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eggert","family":"Stockfleth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"key":"10.3238\/arztebl.2014.0188_ref1","doi-asserted-by":"crossref","unstructured":"Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905\u201313.","DOI":"10.1111\/j.1600-6143.2004.00450.x"},{"key":"10.3238\/arztebl.2014.0188_ref2","doi-asserted-by":"crossref","unstructured":"Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605\u201312.","DOI":"10.1056\/NEJM200003023420901"},{"key":"10.3238\/arztebl.2014.0188_ref3","doi-asserted-by":"crossref","unstructured":"Ulrich C, Hackethal M, Meyer T, et al.: Skin infections in organ transplant recipients. J Dtsch Dermatol Ges 2008; 6: 98\u2013105.","DOI":"10.1111\/j.1610-0387.2007.06431.x"},{"key":"10.3238\/arztebl.2014.0188_ref4","doi-asserted-by":"crossref","unstructured":"Wisgerhof HC, Edelbroek JR, Fijter JW, et al.: Trends of skin diseases in organ transplant recipients transplanted between 1966 and 2006: A cohort study with follow-up between 1994 and 2006 Br J Dermatol 2010; 162: 390\u20136.","DOI":"10.1111\/j.1365-2133.2009.09529.x"},{"key":"10.3238\/arztebl.2014.0188_ref5","doi-asserted-by":"crossref","unstructured":"Wimmer CD, Rentsch M, Crispin A, et al.: The janus face of immunosuppression \u2013 de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007; 71: 1271\u20138.","DOI":"10.1038\/sj.ki.5002154"},{"key":"10.3238\/arztebl.2014.0188_ref6","doi-asserted-by":"crossref","unstructured":"Na R, Grulich AE, Meagher NS, McCaughan GW, Keogh AM, Vajdic CM: Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. Am J Transplant 2013; 13: 174\u201383.","DOI":"10.1111\/j.1600-6143.2012.04302.x"},{"key":"10.3238\/arztebl.2014.0188_ref7","doi-asserted-by":"crossref","unstructured":"Zwald FO, Brown M: Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263\u201379.","DOI":"10.1016\/j.jaad.2010.11.063"},{"key":"10.3238\/arztebl.2014.0188_ref8","doi-asserted-by":"crossref","unstructured":"Euvrard S, Kanitakis J, Claudy A: Skin cancer after organ transplantation. N Engl J Med 2003; 348: 1681\u201391.","DOI":"10.1056\/NEJMra022137"},{"key":"10.3238\/arztebl.2014.0188_ref9","doi-asserted-by":"crossref","unstructured":"Penn I, First MR: Merkel\u2019s cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68: 1717\u201321.","DOI":"10.1097\/00007890-199912150-00015"},{"key":"10.3238\/arztebl.2014.0188_ref10","doi-asserted-by":"crossref","unstructured":"Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513\u20139.","DOI":"10.1111\/j.1365-2133.2000.03703.x"},{"key":"10.3238\/arztebl.2014.0188_ref11","doi-asserted-by":"crossref","unstructured":"Hafner J, Kunzi W, Weinreich T: Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999; 198: 29\u201332.","DOI":"10.1159\/000018060"},{"key":"10.3238\/arztebl.2014.0188_ref12","doi-asserted-by":"crossref","unstructured":"Carlson GW, Murray DR, Greenlee R, et al.: Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg 2000; 126: 433\u20137.","DOI":"10.1001\/archotol.126.3.433"},{"key":"10.3238\/arztebl.2014.0188_ref13","doi-asserted-by":"crossref","unstructured":"Lonsdorf AS, Becker MR, Stockfleth E, Sch\u00e4kel K, Ulrich C: Primary and secondary prevention of skin cancer in organ transplant recipients. Hautarzt 2010; 61: 195\u2013206.","DOI":"10.1007\/s00105-009-1858-2"},{"key":"10.3238\/arztebl.2014.0188_ref14","doi-asserted-by":"crossref","unstructured":"Bavinck JN, Tieben LM, van der Woude FJ, et al.: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995; 13: 1933\u20138.","DOI":"10.1200\/JCO.1995.13.8.1933"},{"key":"10.3238\/arztebl.2014.0188_ref15","unstructured":"Hardie IR, Strong RW, Hartley LC, Woodruff PW, Clunie GJ: Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87: 177\u201383."},{"key":"10.3238\/arztebl.2014.0188_ref16","doi-asserted-by":"crossref","unstructured":"Joly P, Bastuji-Garin S, Frances C, et al.: Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study. Transplantation 2010; 89: 1224\u201330.","DOI":"10.1097\/TP.0b013e3181d7598b"},{"key":"10.3238\/arztebl.2014.0188_ref17","unstructured":"Kripke ML: Ultraviolet radiation and immunology: something new under the sun\u2014presidential address. Cancer Res 1994; 54: 6102\u20135."},{"key":"10.3238\/arztebl.2014.0188_ref18","doi-asserted-by":"crossref","unstructured":"Ulrich C, J\u00fcrgensen JS, Degen A, et al.: Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161: 78\u201384.","DOI":"10.1111\/j.1365-2133.2009.09453.x"},{"key":"10.3238\/arztebl.2014.0188_ref19","doi-asserted-by":"crossref","unstructured":"Dantal J, Hourmant M, Cantarovich D, et al.: Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351: 623\u20138.","DOI":"10.1016\/S0140-6736(97)08496-1"},{"key":"10.3238\/arztebl.2014.0188_ref20","doi-asserted-by":"crossref","unstructured":"O'Donovan P, Perrett CM, Zhang X, et al.: Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871\u20134.","DOI":"10.1126\/science.1114233"},{"key":"10.3238\/arztebl.2014.0188_ref21","doi-asserted-by":"crossref","unstructured":"Hofbauer GF, Attard NR, Harwood CA, et al.: Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine. Am J Transplant 2012; 12: 218\u201325.","DOI":"10.1111\/j.1600-6143.2011.03751.x"},{"key":"10.3238\/arztebl.2014.0188_ref22","doi-asserted-by":"crossref","unstructured":"Jensen P, Hansen S, M\u00f8ller B, et al.: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177\u201386.","DOI":"10.1016\/S0190-9622(99)70185-4"},{"key":"10.3238\/arztebl.2014.0188_ref23","doi-asserted-by":"crossref","unstructured":"Euvrard S, Morelon E, Rostaing L, et al. for the TUMORAPA Study Group: Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 2012; 367: 329\u201339.","DOI":"10.1056\/NEJMoa1204166"},{"key":"10.3238\/arztebl.2014.0188_ref24","doi-asserted-by":"crossref","unstructured":"Euvrard S, Ulrich C, Lefrancois N: Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004; 30: 628\u201333.","DOI":"10.1111\/j.1524-4725.2004.30148.x"},{"key":"10.3238\/arztebl.2014.0188_ref25","doi-asserted-by":"crossref","unstructured":"Salgo R, Gossmann J, Sch\u00f6fer H, et al.: Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 2010; 10: 1385\u201393.","DOI":"10.1111\/j.1600-6143.2009.02997.x"},{"key":"10.3238\/arztebl.2014.0188_ref26","unstructured":"Otley CC, Coldiron BM, Stasko T, Goldman GD: Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137: 459\u201363."},{"key":"10.3238\/arztebl.2014.0188_ref27","doi-asserted-by":"crossref","unstructured":"Wisgerhof HC, Edelbroek JR, de Fijter JW, Feltkamp MC, Willemze R, Bouwes Bavinck JN: Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006. Br J Dermatol 2010; 162: 390\u20136.","DOI":"10.1111\/j.1365-2133.2009.09529.x"},{"key":"10.3238\/arztebl.2014.0188_ref28","doi-asserted-by":"crossref","unstructured":"Wolf IH: Skin infections after transplantation. Hautarzt 2010; 61: 230\u20133.","DOI":"10.1007\/s00105-009-1859-1"},{"key":"10.3238\/arztebl.2014.0188_ref29","doi-asserted-by":"crossref","unstructured":"Ulrich C, Hackethal M, Meyer T, et al.: Skin infections in organ transplant recipients. J Dtsch Dermatol Ges 2008; 6: 98\u2013105.","DOI":"10.1111\/j.1610-0387.2007.06431.x"},{"key":"10.3238\/arztebl.2014.0188_ref30","doi-asserted-by":"crossref","unstructured":"Kralund HH, Broesby-Olsen S, Bistrup C, Lorentzen HF: Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report. Transplantation 2011; 91: 52\u20134.","DOI":"10.1097\/TP.0b013e31820f08d0"},{"key":"10.3238\/arztebl.2014.0188_ref31","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger-Corcoran D, Stockfleth E, J\u00fcrgensen JS, et al.: Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management. Hautarzt 2010; 61: 220\u20139.","DOI":"10.1007\/s00105-009-1860-8"},{"key":"10.3238\/arztebl.2014.0188_ref32","doi-asserted-by":"crossref","unstructured":"Christenson LJ, Geusau A, Ferrandiz C, et al.: Specialty clinics for the dermatologic care of solid-organ transplant recipients. Dermatol Surg 2004; 30: 598\u2013603.","DOI":"10.1111\/j.1524-4725.2004.00143.x"},{"key":"10.3238\/arztebl.2014.0188_ref33","doi-asserted-by":"crossref","unstructured":"Otley CC, Hirose R, Salasche SJ: Skin cancer as a contraindication to organ transplantation. Am J Transplant 2005; 5: 2079\u201384.","DOI":"10.1111\/j.1600-6143.2005.01036.x"},{"key":"10.3238\/arztebl.2014.0188_ref34","doi-asserted-by":"crossref","unstructured":"Mudigonda T, Levender MM, O'Neill JL, West CE, Pearce DJ, Feldman SR: Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010. Dermatol Surg 2013; 39: 345\u201364.","DOI":"10.1111\/dsu.12028"},{"key":"10.3238\/arztebl.2014.0188_ref35","doi-asserted-by":"crossref","unstructured":"Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T: Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation 2012; 94: 990\u20138.","DOI":"10.1097\/TP.0b013e318270bc7b"},{"key":"10.3238\/arztebl.2014.0188_ref36","doi-asserted-by":"crossref","unstructured":"Lott DG, Manz R, Koch C, Lorenz R: Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients. Transplantation 2010; 90: 683\u20137.","DOI":"10.1097\/TP.0b013e3181ec7228"},{"key":"10.3238\/arztebl.2014.0188_ref37","doi-asserted-by":"crossref","unstructured":"Wisgerhof HC, Edelbroek JR, de Fijter JW, et al.: Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010; 89: 1231\u20138.","DOI":"10.1097\/TP.0b013e3181d84cdc"},{"key":"10.3238\/arztebl.2014.0188_ref38","unstructured":"Berman B, Cohen DE, Amini S: What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies. Cutis 2012; 89: 294\u2013301."},{"key":"10.3238\/arztebl.2014.0188_ref39","doi-asserted-by":"crossref","unstructured":"Ulrich C, Bichel J, Euvrard S, et al.: Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 2007; 157: 25\u201331.","DOI":"10.1111\/j.1365-2133.2007.08269.x"},{"key":"10.3238\/arztebl.2014.0188_ref40","doi-asserted-by":"crossref","unstructured":"Ulrich C, Johannsen A, R\u00f6wert-Huber J, Ulrich M, Sterry W, Stockfleth E: Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. Eur J Dermatol 2010; 20: 482\u20138.","DOI":"10.1684\/ejd.2010.1010"},{"key":"10.3238\/arztebl.2014.0188_ref41","doi-asserted-by":"crossref","unstructured":"Piaserico S, Belloni Fortina A, Rigotti P, et al.: Topical photodynamic therapy of actinic keratosis in renal transplant patients. Transplant Proc 2007; 39: 1847\u201350.","DOI":"10.1016\/j.transproceed.2007.05.040"},{"key":"10.3238\/arztebl.2014.0188_ref42","doi-asserted-by":"crossref","unstructured":"Wennberg AM, Stenquist B, Stockfleth E, et al.: Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008; 86: 423\u20139.","DOI":"10.1097\/TP.0b013e318180731e"},{"key":"10.3238\/arztebl.2014.0188_ref43","doi-asserted-by":"crossref","unstructured":"Dragieva C, Hafner J, Dummer R, et al.: Topical photodynamic therapy in the treatment of actinic keratoses and Bowen\u2019s disease in transplant recipients. Transplantation 2004; 77: 115\u201321.","DOI":"10.1097\/01.TP.0000107284.04969.5C"},{"key":"10.3238\/arztebl.2014.0188_ref44","doi-asserted-by":"crossref","unstructured":"Perrett CM, McGregor JM, Warwick J, et al.: Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 2007; 156: 320\u20138.","DOI":"10.1111\/j.1365-2133.2006.07616.x"},{"key":"10.3238\/arztebl.2014.0188_ref45","doi-asserted-by":"crossref","unstructured":"Dragieva C, Prinz BM, Hafner J, et al.: A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196\u2013200.","DOI":"10.1111\/j.1365-2133.2004.06054.x"},{"key":"10.3238\/arztebl.2014.0188_ref46","doi-asserted-by":"crossref","unstructured":"Willey A, Mehta S, Lee PK: Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010; 36: 652\u20138.","DOI":"10.1111\/j.1524-4725.2009.01384.x"},{"key":"10.3238\/arztebl.2014.0188_ref47","doi-asserted-by":"crossref","unstructured":"Perrett CM, Tan SK, Cerio R, et al.: Treatment of a basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient. Clin Exp Dermatol 2006; 31: 146\u20137.","DOI":"10.1111\/j.1365-2230.2005.01949.x"},{"key":"10.3238\/arztebl.2014.0188_ref48","doi-asserted-by":"crossref","unstructured":"Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA: Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25\u20138.","DOI":"10.1080\/00015550510042868"},{"key":"10.3238\/arztebl.2014.0188_ref49","doi-asserted-by":"crossref","unstructured":"De Graaf YG, Kennedy C, Wolterbeek R, et al.: Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organtransplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006; 126: 569\u201374.","DOI":"10.1038\/sj.jid.5700098"},{"key":"10.3238\/arztebl.2014.0188_ref50","doi-asserted-by":"crossref","unstructured":"Green AC, Williams GM, Logan V, Strutton GM: Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29: 257\u201363.","DOI":"10.1200\/JCO.2010.28.7078"},{"key":"10.3238\/arztebl.2014.0188_ref51","doi-asserted-by":"crossref","unstructured":"Green A, Williams G, Neale R, et al.: Daily sunscreen application and betacarotene supplementation in suppression of basal cell and squamous cell carcinomas of the skin. Lancet 1999; 354: 723\u20139.","DOI":"10.1016\/S0140-6736(98)12168-2"},{"key":"10.3238\/arztebl.2014.0188_ref52","doi-asserted-by":"crossref","unstructured":"Thompson SC, Jolley D, Marks R: Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147\u201351.","DOI":"10.1056\/NEJM199310143291602"},{"key":"10.3238\/arztebl.2014.0188_ref53","doi-asserted-by":"crossref","unstructured":"Naylor MF, Boyd A, Smith DW, et al.: High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170\u20135.","DOI":"10.1001\/archderm.131.2.170"},{"key":"10.3238\/arztebl.2014.0188_ref54","doi-asserted-by":"crossref","unstructured":"Stallone G, Schena A, Infante B, et al.: Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317\u201323.","DOI":"10.1056\/NEJMoa042831"},{"key":"10.3238\/arztebl.2014.0188_ref55","doi-asserted-by":"crossref","unstructured":"Rowe DE, Carroll RJ, Day CL Jr: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 26: 976\u201390.","DOI":"10.1016\/0190-9622(92)70144-5"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:55:04Z","timestamp":1693652104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":55,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0188","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}